Net Income (Annual) Chart

Historical Net Income (Annual) Data

View and export this data back to 1996. Start Trial.
Date Value
December 31, 2025 -3.083M
December 31, 2024 -232.27M
December 31, 2023 -257.44M
December 31, 2022 -230.66M
December 31, 2021 -28.72M
December 31, 2020 -182.89M
December 31, 2019 -111.56M
December 31, 2018 -162.04M
December 31, 2017 -120.69M
December 31, 2016 -127.00M
December 31, 2015 -87.88M
December 31, 2014 -42.49M
December 31, 2013 -30.07M
December 31, 2012 -11.32M
December 31, 2011 -23.28M
Date Value
December 31, 2010 -21.91M
December 31, 2009 -30.32M
December 31, 2008 -30.80M
December 31, 2007 -36.80M
December 31, 2006 -51.88M
December 31, 2005 -74.10M
December 31, 2004 -68.75M
December 31, 2003 -65.93M
December 31, 2002 -55.88M
December 31, 2001 -73.54M
December 31, 2000 -46.73M
December 31, 1999 -18.12M
December 31, 1998 -8.904M
December 31, 1997 -3.832M
December 31, 1996 -3.346M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Annual) Range, Past 5 Years

View Net Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Annual) Benchmarks

View Net Income (Annual) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. 316.89M
AVITA Medical, Inc. -48.59M
Iovance Biotherapeutics, Inc. -390.98M
Amgen, Inc. 7.711B
Anika Therapeutics, Inc. -9.979M